实时快讯
政策法规 现行有效美国危险品合规

§ 107.705 Registrations, reports, and applications for approval.

效力法规类型发布日期生效日期发文机构
现行有效部门规章2026-08-072026-09-08Code of Federal Regulations (CFR) - Transportation (Title 49)
发布08-07
生效09-08
摘要总结AI 辅助解读
本条款规定了向美国运输部管道和危险品安全管理局(PHMSA)提交危险品注册、报告或审批申请的具体程序要求。申请人必须通过指定地址、传真或电子邮件提交文件,并明确引用相关法规章节及提供完整的联系人与活动描述信息。对于非美国居民,需指定送达代理人。特别地,涉及豁免监管要求的审批申请需提供风险评估与安全等效性证明;锂电池医疗设备的运输申请需说明目的地航空服务频率。此外,若希望在现有审批到期前至少60天提交续期申请,可维持审批有效性直至行政决定作出,否则过期后禁止操作。
官方原文
外文原文 · 可AI翻译 · 可溯源
  • (a) A person filing a registration, report, or application for an approval, or a renewal or modification of an approval subject to the provisions of this subpart must—

- (1) File the registration, report, or application with the Associate Administrator for Hazardous Materials Safety (Attention: Approvals, PHH-32), Pipeline and Hazardous Materials Safety Administration, U.S. Department of Transportation, East Building, 1200 New Jersey Avenue, SE., Washington, DC 20590-0001. Alternatively, the document with any attached supporting documentation in an appropriate format may be filed by facsimile (fax) to: (202) 366-3753 or (202) 366-3308 or by electronic mail (e-mail) to: approvals@dot.gov.

- (2) Identify the section of the chapter under which the registration, report, or application is made;

- (3) If a report is required by an approval, a registration or a special permit, identify the approval, registration or special permit number;

- (4) Provide the name, street and mailing addresses, e-mail address optional, and telephone number of the person on whose behalf the registration, report, or application is made and, if different, the person making the filing;

- (5) If the person on whose behalf the filing is made is not a resident of the United States, provide a designation of agent for service in accordance with § 105.40;

- (6) Provide a description of the activity for which the registration or report is required; and

- (7) Provide additional information as requested by the Associate Administrator, if the Associate Administrator determines that a filing lacks pertinent information or otherwise does not comply with applicable requirements.

  • (b) Description of approval proposal. In addition to the provisions in paragraph (a) for an approval, an application for an approval, or an application for modification or renewal of an approval, the applicant must include the following information that is relevant to the approval application—

- (1) A description of the activity for which the approval is required;

- (2) The proposed duration of the approval;

- (3) The transport mode or modes affected, as applicable;

- (4) Any additional information specified in the section containing the approval;

- (5) For an approval which provides exceptions from regulatory requirements or prohibitions—

  • (i) Identification of any increased risk to safety or property that may result if the approval is granted, and specification of the measures that the applicant considers necessary or appropriate to address that risk; and

- (ii) Substantiation, with applicable analyses or evaluations, if appropriate, demonstrating that the proposed activity will achieve a level of safety that is at least equal to that required by the regulation; and

- (6) For lithium cells and batteries used for a medical device and transported in accordance with § 173.185(g) of this chapter, details on the extent to which the destination(s) of the lithium cell or battery is not serviced daily by cargo aircraft.

  • (c) For an approval with an expiration date, each application for renewal or modification must be filed in the same manner as an original application. If, at least 60 days before an existing approval expires the holder files an application for renewal that is complete and conforms to the requirements of this section, the approval will not expire until final administrative action on the application for renewal has been taken. Operation under an expired approval not filed within 60 days of the expiration date is prohibited. This paragraph does not limit the authority of the Associate Administrator to modify, suspend or terminate an approval under § 107.713.
  • (d) To request confidential treatment for information contained in the application, the applicant shall comply with § 105.30(a).
[Amdt. 107-38, 61 FR 21100, May 9, 1996, as amended at 65 FR 50457, Aug. 18, 2000; 67 FR 61011, Sept. 27, 2002; 70 FR 56090, Sept. 23, 2005; 70 FR 73162, Dec. 9, 2005; 72 FR 55683, Oct. 1, 2007; 79 FR 15043, Mar. 18, 2014; 80 FR 54437, Sept. 10, 2015; 87 FR 78010, Dec. 21, 2022]
§
免责声明:以上内容通过公开渠道搜集整理,仅供业界参考与内部交流使用,不构成任何形式的商业决策指导或法律建议;实际执行标准请以官方机构发布的最新原文及主管部门解释为准。 摘要、条款解读与影响分析内容由 AI 辅助生成,仅供参考,不构成法律意见;原文更新后解读将同步重新生成。